Switch to:
Sanofi SA (NYSE:SNY)
Research and Development
$5,615 Mil (TTM As of Dec. 2015)

This is the expense the company spent on research and development. Sanofi SA's research and development for the three months ended in Dec. 2015 was $1,349 Mil. Its research and development for the trailing twelve months (TTM) ended in Dec. 2015 was $5,615 Mil.


Definition

This is the expense the company spent on research and development.

Sanofi SA Research & Development for the trailing twelve months (TTM) ended in Dec. 2015 was 1297.61904762 (Mar. 2015 ) + 1447.81144781 (Jun. 2015 ) + 1520.76318743 (Sep. 2015 ) + 1348.583878 (Dec. 2015 ) = $5,615 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Sanofi SA Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
Research & Development 5,8526,6146,1826,6815,8216,3306,4596,5435,9485,536

Sanofi SA Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
Research & Development 1,7091,5751,6141,4771,6661,2981,4481,5211,3491,375
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK